Seeking Alpha

Shares of AEterna Zentaris (AEZS +13.7%) and Metabolix (MBLX +10.1%) jump after the companies...

Shares of AEterna Zentaris (AEZS +13.7%) and Metabolix (MBLX +10.1%) jump after the companies receive FDA approval for their respective products for bladder cancer treatment (PR) and use in food contact applications (PR).
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector